For patients in Shreveport, Bossier City, and across Louisiana, GLP-1 weight loss drugs are becoming easier to find, but not always easier to afford. Wegovy, Zepbound, and the newly approved pill Foundayo are drawing attention because they offer more options than patients had even a year ago.
The challenge is that the monthly price can still swing widely depending on dosage, insurance coverage, and whether a savings program still applies.
More Choices Are Showing Up
The biggest shift in 2026 is that this is no longer just a conversation about weekly shots. Wegovy now has a pill option, and Foundayo entered the market this month as another oral GLP-1 choice. That matters because many patients are more comfortable with a pill than an injection, and the lower starting price can make the first month feel more realistic.
Still, the starting number does not tell the whole story. Official pricing pages show some self-pay offers beginning around $149 a month, while injectable options can start lower for an intro period and then jump higher after those first fills. That means a prescription that looks manageable in month one may not feel nearly as manageable by month three.
Insurance Is Still the Wild Card
This is where many Louisiana families hit the wall. Recent reporting found that only a small share of large employer health plans covered GLP-1 drugs specifically for weight loss. When coverage does exist, the out-of-pocket cost can be far more reasonable…